News on Qiagen from BioPortfolio.com http://www.BioPortfolio.com Consolidated Qiagen news from BioPortfolio.com Wed, 10 Feb 2010 15:13:44 GMT en Abbot Sues Qiagen Over Pact for PCR-Based HPV Detection Methodshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039465&HITNO=0&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039465&THISHREF=http://c.moreover.com/click/here.pl%3fz2538127238%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039465&HITNO=0&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039465&THISHREF=http://c.moreover.com/click/here.pl%3fz2538127238%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Qiagen's Revenues Rise 22 Percent in Q4, Eclipse $1B Mark for FY 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041233&HITNO=1&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041233&THISHREF=http://c.moreover.com/click/here.pl%3fz2539043169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041233&HITNO=1&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041233&THISHREF=http://c.moreover.com/click/here.pl%3fz2539043169%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Qiagen Licenses Biomarker IP from Johns Hopkinshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041236&HITNO=2&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041236&THISHREF=http://c.moreover.com/click/here.pl%3fz2539044764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041236&HITNO=2&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041236&THISHREF=http://c.moreover.com/click/here.pl%3fz2539044764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Pfizer, Bayer, and BMS Advance Personalized Medicine Productshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040495&HITNO=3&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040495&THISHREF=http://c.moreover.com/click/here.pl%3fz2538770981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040495&HITNO=3&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040495&THISHREF=http://c.moreover.com/click/here.pl%3fz2538770981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Reportlinker Adds Assessment of the Molecular Diagnostic Market for 44 NA Tests in Francehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042226&HITNO=4&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042226&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042226&HITNO=4&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042226&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKSLA: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033871&HITNO=5&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033871&THISHREF=http://c.moreover.com/click/here.pl%3fz2535463196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033871&HITNO=5&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033871&THISHREF=http://c.moreover.com/click/here.pl%3fz2535463196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032361&HITNO=6&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032361&THISHREF=http://c.moreover.com/click/here.pl%3fz2534625056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032361&HITNO=6&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032361&THISHREF=http://c.moreover.com/click/here.pl%3fz2534625056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPoten & Partners: QIAGEN Acquires Exclusive Licence for Key PI3K gene - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032524&HITNO=7&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032524&THISHREF=http://c.moreover.com/click/here.pl%3fz2534690649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032524&HITNO=7&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032524&THISHREF=http://c.moreover.com/click/here.pl%3fz2534690649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033854&HITNO=8&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033854&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033854&HITNO=8&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033854&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038130&HITNO=9&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038130&THISHREF=http://c.moreover.com/click/here.pl%3fz2537492439%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038130&HITNO=9&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038130&THISHREF=http://c.moreover.com/click/here.pl%3fz2537492439%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033173&HITNO=10&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033173&THISHREF=http://c.moreover.com/click/here.pl%3fz2535050741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033173&HITNO=10&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033173&THISHREF=http://c.moreover.com/click/here.pl%3fz2535050741%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDallas Business Chronicle: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033055&HITNO=11&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033055&THISHREF=http://c.moreover.com/click/here.pl%3fz2534966795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033055&HITNO=11&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033055&THISHREF=http://c.moreover.com/click/here.pl%3fz2534966795%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWichita Business Journal: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032965&HITNO=12&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032965&THISHREF=http://c.moreover.com/click/here.pl%3fz2534924419%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032965&HITNO=12&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032965&THISHREF=http://c.moreover.com/click/here.pl%3fz2534924419%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Jose Business Journal: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032908&HITNO=13&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032908&THISHREF=http://c.moreover.com/click/here.pl%3fz2534874656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032908&HITNO=13&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032908&THISHREF=http://c.moreover.com/click/here.pl%3fz2534874656%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Tampa Bay: QIAGEN Acquires Exclusive Licence for Key PI3K genehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032781&HITNO=14&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032781&THISHREF=http://c.moreover.com/click/here.pl%3fz2534821425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032781&HITNO=14&MSIZE=260&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Qiagen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032781&THISHREF=http://c.moreover.com/click/here.pl%3fz2534821425%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAtlanta Business Chronicle: